Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy. (31st December 2022) - Lin, Brian; Shin, Joseph; Jeffreys, Will; Lukban, Clarisse; Hanselman, Olivia; Kwon, Seoyoung; Wang, Nadan; Pullen, Steven; Filareto, Antonio; Kass, David